Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

Erscheinungsjahr
Treffer 1 - 25 von 165, Suchdauer: 1.26s
  • 11

    von Lau L.M.S. ; Baber J. ; Priestley P. ; et al.

    Schlagworte: SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily B member 1/ec [Endogenous Compound]; transcription factor EZH2/ec [Endogenous Compound]; transcriptional regulator ATRX/ec [Endogenous Compound]; transcriptome/ec [Endogenous Compound]; unclassified drug; cdkn2a/b protein/ec [Endogenous Compound]; h3f3a protein/ec [Endogenous Compound]; kit protein/ec [Endogenous Compound]; mycn protein/ec [Endogenous Compound]; nf1 protein/ec [Endogenous Compound]; nras protein/ec [Endogenous Compound]; pdfgra protein/ec [Endogenous Compound]; pik3ca protein/ec [Endogenous Compound]; pik3r1 protein/ec [Endogenous Compound]; PIK3R2 protein/ec [Endogenous Compound]; rb1 protein/ec [Endogenous Compound]; protein tyrosine phosphatase SHP 2/ec [Endogenous Compound]; epidermal growth factor receptor/ec [Endogenous Compound]; adult; article; cancer chemotherapy; cancer patient; cancer risk; cancer susceptibility; central nervous system tumor; childhood cancer/dt [Drug Therapy]; chromosome 1q; chromosome arm; classifier; cohort analysis; controlled study; feasibility study; follow up; gene amplification; gene expression; germline mutation; hematologic malignancy; human; loss of function mutation; major clinical study; methylome; molecular fingerprinting; neuroblastoma; pilot study; point mutation; priority journal; prospective study; RNA sequencing; sarcoma; signal transduction; single nucleotide polymorphism; solid malignant neoplasm; treatment response; tumor associated leukocyte; whole genome sequencing; young adult; antineoplastic agent/cb [Drug Combination]; antineoplastic agent/dt [Drug Therapy]; ATM protein/ec [Endogenous Compound]; BRG1 protein/ec [Endogenous Compound]; cyclin dependent kinase 4/ec [Endogenous Compound]; cyclin dependent kinase inhibitor/cb [Drug Combination]; epidermal growth factor receptor 2/ec [Endogenous Compound]; fibroblast growth factor receptor 1/ec [Endogenous Compound]; mammalian target of rapamycin/ec [Endogenous Compound]; mammalian target of rapamycin complex 1/ec [Endogenous Compound]; mammalian target of rapamycin complex 2/ec [Endogenous Compound]; mammalian target of rapamycin inhibitor/cb [Drug Combination]; mammalian target of rapamycin inhibitor/dt [Drug Therapy]; Myc protein/ec [Endogenous Compound]; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor/cb [Drug Combination]; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor/dt [Drug Therapy]; phosphatidylinositol 3 kinase/ec [Endogenous Compound]; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase/ec [Endogenous Compound]; protein/ec [Endogenous Compound]; protein kinase B/ec [Endogenous Compound]; protein p53/ec [Endogenous Compound]; cyclin dependent kinase inhibitor/dt [Drug Therapy]; Article

    Kein Bild verfügbar